Artificial Intelligence
Powered by Lunit SCOPE PD-L1, the Guardant360 TissueNext PD-L1 test with Guardant Galaxy™ shows improved detection of the biomarker in NSCLC Lunit's AI solution is the first application in Guardant Galaxy, a suite of AI and other...
Gestalt: Looking beyond 2023 By Charles Best The exciting digital pathology pivot was initially driven by the necessity during the pandemic. Looking beyond the initial drivers, adoption is continuing at a pace that has been...
Akoya Collaborating with Agilent to Catalyze Precision Medicine We recently announced a partnership with Agilent to develop multiplex diagnostic solutions for tissue analysis and to commercialize workflow solutions for these...
Ibex: Our AI Algorithm to Aid Pathologists with Accurate and Reproducible HER2 and HER2-low Assessment in Breast Cancer Diagnosis TEL AVIV, Israel, Jan. 24, 2023 /PRNewswire/ -- Ibex Medical Analytics (Ibex), the leader in AI-powered cancer...
Crescendo Health’s real-world data platform creates partnerships between researchers and patients to gain greater longitudinal insights into health outcomes from clinical research. Company also raises initial funding from top investors;...
Today, Nature Medicine published groundbreaking Owkin research demonstrating the first-ever use of federated learning to train deep learning models on multiple hospitals’ histopathology data. At Owkin, we are on a journey to...
